161 related articles for article (PubMed ID: 16893075)
1. Complement activation during sepsis in humans.
Schreiber H; Rittirsch D; Flierl M; Brueckner U; Schneider M; Weiss M; Gebhard F; Huber-Lang M
Adv Exp Med Biol; 2006; 586():217-26. PubMed ID: 16893075
[No Abstract] [Full Text] [Related]
2. In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells.
Shivshankar P; Li YD; Mueller-Ortiz SL; Wetsel RA
FASEB J; 2020 Jun; 34(6):7540-7560. PubMed ID: 32301538
[TBL] [Abstract][Full Text] [Related]
3. New concepts on the therapeutic control of complement anaphylatoxin receptors.
Hawksworth OA; Li XX; Coulthard LG; Wolvetang EJ; Woodruff TM
Mol Immunol; 2017 Sep; 89():36-43. PubMed ID: 28576324
[TBL] [Abstract][Full Text] [Related]
4. Food intake regulation by central complement system.
Ohinata K; Yoshikawa M
Adv Exp Med Biol; 2008; 632():35-46. PubMed ID: 19025112
[TBL] [Abstract][Full Text] [Related]
5. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
Oppermann M; Götze O
Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
[TBL] [Abstract][Full Text] [Related]
6. Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a.
Gutzmer R; Köther B; Zwirner J; Dijkstra D; Purwar R; Wittmann M; Werfel T
J Invest Dermatol; 2006 Nov; 126(11):2422-9. PubMed ID: 16778800
[TBL] [Abstract][Full Text] [Related]
7. Complement Activation in Arterial and Venous Thrombosis is Mediated by Plasmin.
Foley JH; Walton BL; Aleman MM; O'Byrne AM; Lei V; Harrasser M; Foley KA; Wolberg AS; Conway EM
EBioMedicine; 2016 Mar; 5():175-82. PubMed ID: 27077125
[TBL] [Abstract][Full Text] [Related]
8. Complement peptides and mast cell triggering.
Erdei A; Pecht I
Immunol Lett; 1996 Dec; 54(2-3):109-12. PubMed ID: 9052863
[TBL] [Abstract][Full Text] [Related]
9. Complement in sepsis-when science meets clinics.
Mollnes TE; Huber-Lang M
FEBS Lett; 2020 Aug; 594(16):2621-2632. PubMed ID: 32621378
[TBL] [Abstract][Full Text] [Related]
10. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation.
Rinder CS; Rinder HM; Smith BR; Fitch JC; Smith MJ; Tracey JB; Matis LA; Squinto SP; Rollins SA
J Clin Invest; 1995 Sep; 96(3):1564-72. PubMed ID: 7657827
[TBL] [Abstract][Full Text] [Related]
11. Complement C5a Functions as a Master Switch for the pH Balance in Neutrophils Exerting Fundamental Immunometabolic Effects.
Denk S; Neher MD; Messerer DAC; Wiegner R; Nilsson B; Rittirsch D; Nilsson-Ekdahl K; Weckbach S; Ignatius A; Kalbitz M; Gebhard F; Weiss ME; Vogt J; Radermacher P; Köhl J; Lambris JD; Huber-Lang MS
J Immunol; 2017 Jun; 198(12):4846-4854. PubMed ID: 28490576
[TBL] [Abstract][Full Text] [Related]
12. Carboxypeptidase B2 deficiency reveals opposite effects of complement C3a and C5a in a murine polymicrobial sepsis model.
Shao Z; Nishimura T; Leung LL; Morser J
J Thromb Haemost; 2015 Jun; 13(6):1090-102. PubMed ID: 25851247
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil extracellular traps can activate alternative complement pathways.
Wang H; Wang C; Zhao MH; Chen M
Clin Exp Immunol; 2015 Sep; 181(3):518-27. PubMed ID: 25963026
[TBL] [Abstract][Full Text] [Related]
14. The role of C3a and C5a in hyperacute rejection of guinea pig-to-rat cardiac xenografts.
Pruitt SK; Baldwin WM; Sanfilippo F
Transplant Proc; 1996 Apr; 28(2):596. PubMed ID: 8623292
[No Abstract] [Full Text] [Related]
15. Differential effects of complement activation products c3a and c5a on cardiovascular function in hypertensive pregnant rats.
Lillegard KE; Loeks-Johnson AC; Opacich JW; Peterson JM; Bauer AJ; Elmquist BJ; Regal RR; Gilbert JS; Regal JF
J Pharmacol Exp Ther; 2014 Nov; 351(2):344-51. PubMed ID: 25150279
[TBL] [Abstract][Full Text] [Related]
16. C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a.
Chen NJ; Mirtsos C; Suh D; Lu YC; Lin WJ; McKerlie C; Lee T; Baribault H; Tian H; Yeh WC
Nature; 2007 Mar; 446(7132):203-7. PubMed ID: 17322907
[TBL] [Abstract][Full Text] [Related]
17. Complement factors and their receptors.
Ember JA; Hugli TE
Immunopharmacology; 1997 Dec; 38(1-2):3-15. PubMed ID: 9476110
[TBL] [Abstract][Full Text] [Related]
18. A novel interpretation of immune redundancy and duality in reperfusion injury with important implications for intervention in ischaemic disease.
Thrane AS; Skehan JD; Thrane PS
Med Hypotheses; 2007; 68(6):1363-70. PubMed ID: 17169498
[TBL] [Abstract][Full Text] [Related]
19. Complement C5a in the sepsis syndrome--too much of a good thing?
Gerard C
N Engl J Med; 2003 Jan; 348(2):167-9. PubMed ID: 12519929
[No Abstract] [Full Text] [Related]
20. The role of the complement anaphylatoxins in the recruitment of eosinophils.
DiScipio RG; Schraufstatter IU
Int Immunopharmacol; 2007 Dec; 7(14):1909-23. PubMed ID: 18039528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]